EEG-Based Prediction of rTMS Treatment Response in Depression: Nonlinear Features and Machine Learning with Minimal Electrode
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Repetitive transcranial magnetic stimulation (rTMS) is an established intervention for treatment-resistant depression, but response rates remain highly variable and reliable predictors of outcome are lacking. Resting-state electroencephalography (EEG), combined with machine learning, represents a cost-effective and accessible approach for individualized treatment planning.
Methods
One hundred patients with major depressive disorder (MDD; 51 responders, 49 non-responders) underwent pre-treatment resting-state EEG prior to rTMS. Recordings were obtained using either 8 or 30 electrodes. Features including band power, coherence, phase-lag index (PLI), and phase-locking value (PLV) were extracted. Machine learning models were constructed using two-stage feature selection (recursive feature elimination with support vector classifier and sequential backward selection) and linear discriminant analysis (LDA). Model performance was assessed with 5-fold cross-validation and 1,000 shuffle iterations.
Results
Multi-feature EEG models consistently outperformed single-feature approaches in predicting rTMS treatment response. The best-performing model, based on only 8 electrodes, achieved an accuracy of 78.9% and an AUC of 73.3%, surpassing the 30-electrode configuration. PLI emerged as the strongest individual predictor, but combining multiple EEG features substantially improved classification. LDA provided the most stable performance across limited datasets.
Conclusions
Resting-state EEG combined with machine learning can reliably predict rTMS treatment response in MDD. Notably, accurate prediction was achieved with a minimal 8-electrode montage, supporting the clinical feasibility of low-cost EEG assessments. This approach may facilitate personalized treatment selection and improve rTMS outcomes in routine psychiatric care.
